BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 34758826)

  • 21. Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.
    Leibowitz MS; Andrade Filho PA; Ferrone S; Ferris RL
    Cancer Immunol Immunother; 2011 Apr; 60(4):525-35. PubMed ID: 21207025
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of signal transducer and activator of transcription 1 (STAT1) is not sufficient for the induction of STAT1-dependent genes in endothelial cells. Comparison of interferon-gamma and oncostatin M.
    Mahboubi K; Pober JS
    J Biol Chem; 2002 Mar; 277(10):8012-21. PubMed ID: 11777927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.
    Beniers AJ; Peelen WP; Debruyne FM; Schalken JA
    Int J Cancer; 1991 Jul; 48(5):709-16. PubMed ID: 1906431
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells.
    Cheng CW; Shieh PC; Lin YC; Chen YJ; Lin YH; Kuo DH; Liu JY; Kao JY; Kao MC; Way TD
    J Agric Food Chem; 2010 Jan; 58(2):887-94. PubMed ID: 19928918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiation of interferon induction of class I major histocompatibility complex antigen expression by human tumor necrosis factor in small cell lung cancer cell lines.
    Marley GM; Doyle LA; Ordóñez JV; Sisk A; Hussain A; Yen RW
    Cancer Res; 1989 Nov; 49(22):6232-6. PubMed ID: 2553249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation.
    Zhou F
    Int Rev Immunol; 2009; 28(3-4):239-60. PubMed ID: 19811323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of major histocompatibility class II protein expression by varicella-zoster virus.
    Abendroth A; Slobedman B; Lee E; Mellins E; Wallace M; Arvin AM
    J Virol; 2000 Feb; 74(4):1900-7. PubMed ID: 10644363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Programmed Death Ligand 1 Indicates Pre-Existing Adaptive Immune Response by Tumor-Infiltrating CD8
    Li YM; Yu JM; Liu ZY; Yang HJ; Tang J; Chen ZN
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31627272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFN-γ treatment protocol for MHC-I
    Stifter K; Krieger J; Ruths L; Gout J; Mulaw M; Lechel A; Kleger A; Seufferlein T; Wagner M; Schirmbeck R
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32868392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential regulation of constitutive major histocompatibility complex class I expression in T and B lymphocytes.
    Lee CK; Gimeno R; Levy DE
    J Exp Med; 1999 Nov; 190(10):1451-64. PubMed ID: 10562320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.
    Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L
    Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SHP2 is overexpressed and inhibits pSTAT1-mediated APM component expression, T-cell attracting chemokine secretion, and CTL recognition in head and neck cancer cells.
    Leibowitz MS; Srivastava RM; Andrade Filho PA; Egloff AM; Wang L; Seethala RR; Ferrone S; Ferris RL
    Clin Cancer Res; 2013 Feb; 19(4):798-808. PubMed ID: 23363816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulation of the IFN-γ-STAT1 signaling pathway in a cell line model of large granular lymphocyte leukemia.
    Kulling PM; Olson KC; Hamele CE; Toro MF; Tan SF; Feith DJ; Loughran TP
    PLoS One; 2018; 13(2):e0193429. PubMed ID: 29474442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients.
    Srivastava RM; Trivedi S; Concha-Benavente F; Hyun-Bae J; Wang L; Seethala RR; Branstetter BF; Ferrone S; Ferris RL
    Cancer Immunol Res; 2015 Aug; 3(8):936-45. PubMed ID: 25972070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytokine Signaling in Pediatric Kidney Tumor Cell Lines WT-CLS1, WT-3ab and G-401.
    Fasler-Kan E; Milošević M; Ruggiero S; Aliu N; Cholewa D; Häcker FM; Dekany G; Bartenstein A; Berger SM
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-375 inhibits IFN-γ-induced programmed death 1 ligand 1 surface expression in head and neck squamous cell carcinoma cells by blocking JAK2/STAT1 signaling.
    Wu Q; Zhao Y; Sun Y; Yan X; Wang P
    Oncol Rep; 2018 Mar; 39(3):1461-1468. PubMed ID: 29328389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
    Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
    Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanism underlying defective interferon gamma-induced IDO expression in non-obese diabetic mouse fibroblasts.
    Hosseini-Tabatabaei A; Jalili RB; Li Y; Kilani RT; Moeen Rezakhanlou A; Ghahary A
    PLoS One; 2012; 7(5):e37747. PubMed ID: 22662207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Potential Value of Immunotherapy in Colorectal Cancers: Review of the Evidence for Programmed Death-1 Inhibitor Therapy.
    Toh JWT; de Souza P; Lim SH; Singh P; Chua W; Ng W; Spring KJ
    Clin Colorectal Cancer; 2016 Dec; 15(4):285-291. PubMed ID: 27553906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human parainfluenza virus type 3 up-regulates major histocompatibility complex class I and II expression on respiratory epithelial cells: involvement of a STAT1- and CIITA-independent pathway.
    Gao J; De BP; Banerjee AK
    J Virol; 1999 Feb; 73(2):1411-8. PubMed ID: 9882346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.